Search

Few direct matches — filled in with the latest updates.

Tag: #biomedical3 results

Mozi: Governed LLM Agents for Drug Discovery

Mozi: Governed LLM Agents for Drug Discovery

Mozi introduces a dual-layer architecture for LLM agents in drug discovery, with a Control Plane enforcing governed tool use and reflection-based replanning, and a Workflow Plane structuring canonical pharma stages as composable skill graphs. It integrates data contracts and human-in-the-loop checkpoints to ensure reliability in high-stakes pipelines. Evaluations on PharmaBench show superior accuracy, with case studies demonstrating effective navigation of chemical spaces and toxicity filtering.

Agentic AI Reshapes Biomedical Team Science

Agentic AI Reshapes Biomedical Team Science

Cedars-Sinai team introduces Agentic AI systems with multiple autonomous agents collaborating in biomedical research, shifting from single models to team-like structures. They detail three core algorithms—LLMs, reinforcement learning, and evolutionary algorithms—and seven key features including reasoning, verification, and communication. Published in Nature Biotechnology on Feb 24, 2026.

机器之心MediaFeb 26#multi-agent#biomedical#team-science
UK Biobank Data for Sale in China

UK Biobank Data for Sale in China

The UK government confirmed that health data from UK Biobank, covering 500,000 people, was listed for sale in China. No personally identifiable information was exposed. This incident underscores data security risks in biomedical databases.

BBC TechnologyMediaApr 23#data-breach#privacy#biomedical
China Leads Global AI Patent Applications

China Leads Global AI Patent Applications

China continues to lead global patent applications, with AI and other core technology areas highlighted as key strengths. Global patent filings reached 3.72 million in 2024, more than double the 1.7 million recorded in 2005, while Japan’s share declined from 25% to 8%.

cnBeta (Full RSS)Media25m ago#patent-landscape